Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Maine.
Press releases published on August 20, 2025
Calidi Biotherapeutics Announces Pricing of $6 Million Underwritten Public Offering
GlobeNewswire
·
August 20, 2025
SAN DIEGO, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic …
Longeveron® to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
August 20, 2025
MIAMI, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening, rare pediatric and chronic aging-related conditions, today announced …
American Kidney Fund Launches Podcast, 'The Kidney Collective'
GlobeNewswire
·
August 20, 2025
ROCKVILLE, Md., Aug. 20, 2025 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) is proud to announce the launch of its first-ever podcast, "The Kidney Collective™." Introduced as a seven-episode, limited series, The Kidney Collective gives an intimate …
Regulatory Approval Granted for Commencement of Trinity Biotech’s Offshored and Outsourced Manufacturing of its Flagship Rapid HIV Test, Facilitating Strategic and Financial Performance Transformation
GlobeNewswire
·
August 20, 2025
Approval Facilitates Immediate Offshored and Outsourced Manufacturing Strategic Offshore Manufacturing Move Expected to Drive Gross Margin Expansion, Free Up Working Capital, and Enhance Scalability Transition to Outsourced Production Reduces Fixed Costs …
Eleos Launches AI Scanner to Navigate Medicaid Eligibility Risk in Real Time
GlobeNewswire
·
August 20, 2025
BOSTON, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Eleos, the leading AI platform in post-acute care, today announced the launch of the OBBBA (One Big Beautiful Bill Act) AI scanner, the first real-time tool to proactively detect potential changes to Medicaid …
Femasys Secures UK Regulatory Approval of FemBloc Permanent Birth Control
GlobeNewswire
·
August 20, 2025
--Advances European commercialization strategy following CE mark approval-- ATLANTA, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and …
Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share
GlobeNewswire
·
August 20, 2025
WALTHAM, Mass. and DUBLIN and EMERYVILLE, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company (“Mural”), and XOMA Royalty Corporation (Nasdaq: XOMA), a biotechnology royalty aggregator (“ …
Option Care Health Announces Chief Financial Officer Transition
GlobeNewswire
·
August 20, 2025
BANNOCKBURN, Ill., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced the appointment of …
Earth Science Tech, Inc. Boosts Share Repurchase Program to $10 Million and Extends Authorization Through 2027
GlobeNewswire
·
August 20, 2025
Miami, Fla., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company focused on acquiring and scaling high-potential businesses, today announced its Board of Directors has approved a …
Easy Environmental Solutions Launches Terreplenish Trials in Tanzania, Opening Door to Multi-Unit Deployment
GlobeNewswire
·
August 20, 2025
MANKATO, Minn., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Digital Utilities Ventures, Inc. (OTC: DUTV), operating as Easy Environmental Solutions Inc., today announced a strategic collaboration with the Tanzania Fertilizer Regulatory Authority (TFRA) to advance …
Microbot Medical® Granted U.S. Patent that Significantly Expands Potential Market Applications
GlobeNewswire
·
August 20, 2025
With the Newly Granted IP, the Company’s IP Portfolio for the LIBERTY® System now includes 12 patents granted globally and 57 patent applications pending. The Company Continues to Scale Commercial Readiness Plans for the LIBERTY® System as it Awaits FDA …
Adial Pharmaceuticals Encouraged By U.S. Senate Support for Expanded Clinical Trial Endpoints Beyond Abstinence in Alcohol and Substance Use Disorder Treatments
GlobeNewswire
·
August 20, 2025
GLEN ALLEN, Va., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related …
Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of Ramón Polo as Senior Vice President, Head of Global Regulatory Affairs
GlobeNewswire
·
August 20, 2025
SOUTH SAN FRANCISCO, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS) a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today …
Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share
GlobeNewswire
·
August 20, 2025
WALTHAM, Mass., DUBLIN, Ireland and EMERYVILLE, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company (“Mural”), and XOMA Royalty Corporation (Nasdaq: XOMA), a biotechnology royalty aggregator …
Dror Ortho-Design Launches Global ZSmile Innovation Network Initiative to Transform the Stagnating Aligner Market
GlobeNewswire
·
August 20, 2025
JERUSALEM, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Dror Ortho-Design, Inc. (OTC PINK: DROR), a pioneer in AI-powered orthodontic solutions, today announced the launch of the ZSmile Innovation Network, a global community of dental professionals committed to …
Vivani Medical CEO Adam Mendelsohn to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 10, 2025
GlobeNewswire
·
August 20, 2025
ALAMEDA, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (NASDAQ: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, announced today that CEO Adam Mendelsohn, …
Autonomix Medical, Inc. Granted New European Patent for First-in-Class Catheter-Based Technology
GlobeNewswire
·
August 20, 2025
Global patent estate encompasses 80 issued patents and 40 pending patent applications Strengthens strategic position in a multi-billion-dollar market opportunity across cardiovascular, renal, and other high-burden diseases THE WOODLANDS, TX, Aug. 20, 2025 …
Phathom Pharmaceuticals Clarifies That There Is No Reduction in Lead Shareholder’s Ownership Following Administrative Change to 13D Filing
GlobeNewswire
·
August 20, 2025
FLORHAM PARK, N.J., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), today clarified that a Schedule 13D filing by Frazier Life Sciences, which is expected to be filed later today, August 20, will include administrative …
Inspire Medical Systems, Inc. to Present at the Wells Fargo 2025 Healthcare Conference
GlobeNewswire
·
August 20, 2025
MINNEAPOLIS, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive …
AI in Remote Patient Monitoring (RPM) Market to Reach USD 8,438.5 Million by 2030 | MarketsandMarkets™
GlobeNewswire
·
August 20, 2025
Delray Beach, FL, Aug. 20, 2025 (GLOBE NEWSWIRE) -- The global AI in remote patient monitoring market, valued at US$1551.8 million in 2023, stood at US$1,967.7 million in 2024 and is projected to advance at a resilient CAGR of 27.5% from 2024 to 2030, …